Finerenone clinical trials
Also written Kerendia and BAY94-8862.
How each study uses finerenone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the finerenone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Jul 2021 · KERENDIA · NDA 215341 (FDA, Drugs@FDA)
- European Union
- 16 Feb 2022 · Kerendia · EMEA/H/C/005200 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
74 studies that test it; most in 2026 (22); 1 more planned to start later
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 15 |
| 2025 | 11 |
| 2026 | 22 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 25 · Other 50
Bayer (25) · University Medical Center Groningen (3) · Colorado Prevention Center (3) · Chongqing Medical University (2) · Alexandria University (2) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2) · Steno Diabetes Center Copenhagen (2) · Peter Rossing (2)
Often tested with
Tested in the same studies.
Empagliflozin (6) · Semaglutide (5) · Dapagliflozin (4) · Sotagliflozin (3) · Benazepril (1) · Captopril (1) · Enalapril (1) · Fosinopril (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 16, 4 in phase 3
Studies that test finerenone, phase 3 first.
- Apr 2027A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and ProteinuriaPhase 3 · Bayer
- May 2027"Dapagliflozin vs Dapagliflozin-Finerenone for Albuminuria in CKD With Type 2 Diabetes"Phase 3 · Chittagong Medical College
- Nov 2027A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Phase 3 · Colorado Prevention Center
- Nov 2027A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3 · Colorado Prevention Center
- Nov 2026Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility StudyPhase 4 · Steno Diabetes Center Copenhagen
- Dec 2026Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney DiseasePhase 4 · Alexandria University
- Dec 2026Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.Phase 4 · University of Aarhus
- Feb 2027Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With AlbuminuriaNot applicable · Peking University People's Hospital
- Mar 2027Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary AldosteronismNot applicable · Bangladesh Medical University
- Mar 2027The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR StudyPhase 2 · University of North Carolina, Chapel Hill
Studies
Open first, then newest update. How each study uses finerenone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 75
- QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic NephropathyRecruitingPhase 4Huijie ZhangNCT07775846Written as Finerenone
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionRecruitingPhase 3BayerNCT07192952Written as Finerenone (Kerendia, BAY94-8862)
- Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart FailureRecruitingPhase 3Second Affiliated Hospital, Zhejiang University, School of MedicineNCT07575672Written as Finerenone
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionRecruitingPhase 3BayerNCT07188805Written as Finerenone (Kerendia, BAY94-8862)
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Finerenone
- The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic EffectRecruitingPhase 3The George InstituteNCT06058585Written as Finerenone
- Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With AlbuminuriaNot yet recruitingNot applicablePeking University People's HospitalNCT07849348Written as Finerenone
- A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and ProteinuriaRecruitingPhase 3BayerNCT05457283Written as Finerenone (Kerendia, BAY94-8862)
- Finerenone and Cardiac Remodeling in HFpEFNot yet recruitingPhase 4Assiut UniversityNCT07830940Written as Finerenone
- Finerenone for Premature Ovarian Insufficiency (POI)Not yet recruitingPhase 2The University of Hong Kong-Shenzhen HospitalNCT07815509Written as Finerenone
- A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)RecruitingPhase 3Colorado Prevention CenterNCT06024746Written as Finerenone
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsRecruitingPhase 3Colorado Prevention CenterNCT06008197Written as Finerenone
- Finerenone After Catheter Ablation to Reduce Atrial Fibrillation RecurrenceRecruitingPhase 2National Cheng-Kung University HospitalNCT07799519Written as Finerenone
- Role of Finerenone in African American Veterans With Diabetic Kidney DiseaseNot yet recruitingPhase 4Washington D.C. Veterans Affairs Medical CenterNCT07155694Written as Finerenone 10 MG
- Finerenone for AKI: a Multicenter, Randomized, Placebo-Controlled Feasibility Pilot TrialNot yet recruitingNot applicableJean-Maxime CôtéNCT07775482Written as Finerenone (BAY94-8862 ) 10 mg
- Precision T1D Platform - New Therapies for Cardio-Renal ComplicationsNot yet recruitingPhase 2Oregon Health and Science UniversityNCT07594145Written as Finerenone
- Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart FailureRecruitingPhase 4Juntendo UniversityNCT07397650Written as Finerenone Oral Tablet
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsRecruitingPhase 3Colorado Prevention CenterNCT06033950Written as Finerenone
- Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary AldosteronismRecruitingNot applicableBangladesh Medical UniversityNCT07688928Written as Finerenone
- Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled TrialNot yet recruitingNot applicableHeart Health Research CenterNCT07678151Written as Empagliflozin and Finerenone
See all 75 studies that test finerenone →
Given beside what is tested · 2 — finerenone is usual care or a partner of the new treatment
- Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney DiseaseNot yet recruitingPhase 4First Affiliated Hospital of Wannan Medical CollegeNCT07537088Written as Finerenone
- Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot StudyTerminatedPhase 2Iain BressendorffNCT05897372Written as ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
What changed recently
From the registry's own updates since Oct 17, 2026.
Started recruiting1
- QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic NephropathyNov 10, 2026NCT07775846
Codes
What other systems call finerenone · ClinicalTrials.gg INT006186
- MeSH (NLM) C576501finerenoneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) DE2O63YV8RFINERENONEConfirmed FDA, NLM, Wikidata
- RxNorm 2562811One source FDA
- Wikidata Q21099046finerenoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C169981FinerenoneOne source FDA
- DrugBank DB16165One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C576501 | finerenone | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | DE2O63YV8R | FINERENONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2562811 | — | One source FDA |
| Wikidata | Q21099046 | finerenone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C169981 | Finerenone | One source FDA |
| DrugBank | DB16165 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.